GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Farmaceutica Remedia SA (BSE:RMAH) » Definitions » Other Operating Expense

Farmaceutica Remedia (BSE:RMAH) Other Operating Expense : lei35.1 Mil (TTM As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Farmaceutica Remedia Other Operating Expense?

Farmaceutica Remedia's Other Operating Expense for the three months ended in Dec. 2023 was lei8.0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was lei35.1 Mil.

Farmaceutica Remedia's quarterly Other Operating Expense increased from Jun. 2023 (lei8.8 Mil) to Sep. 2023 (lei9.7 Mil) but then declined from Sep. 2023 (lei9.7 Mil) to Dec. 2023 (lei8.0 Mil).

Farmaceutica Remedia's annual Other Operating Expense increased from Dec. 2021 (lei27.5 Mil) to Dec. 2022 (lei35.1 Mil) and increased from Dec. 2022 (lei35.1 Mil) to Dec. 2023 (lei35.1 Mil).


Farmaceutica Remedia Other Operating Expense Historical Data

The historical data trend for Farmaceutica Remedia's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Farmaceutica Remedia Other Operating Expense Chart

Farmaceutica Remedia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.54 39.94 27.48 35.07 35.09

Farmaceutica Remedia Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.85 8.55 8.84 9.67 8.03

Farmaceutica Remedia Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was lei35.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Farmaceutica Remedia Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Farmaceutica Remedia's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Farmaceutica Remedia (BSE:RMAH) Business Description

Traded in Other Exchanges
N/A
Address
No. 2 Nicolae Balcescu Boulevard, Hunedoara County, Deva, ROU, 330040
Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.

Farmaceutica Remedia (BSE:RMAH) Headlines

No Headlines